Amidol Injection 300 mg/ml is a contrast agent used in various radiological imaging procedures, including computed tomography (CT) scans and myelography. It is classified as a non-ionic, water-soluble iodinated contrast medium that helps enhance the visibility of internal structures in imaging studies.
Amidol Injection 300 mg/ml is used for:
| Brand Name | Amidol |
|---|---|
| Type | Injection |
| Weight | 300 mg/ml |
| Generic | Iopamidol |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Amidol Injection 300 mg/ml works by increasing the contrast between tissues of differing densities in imaging studies. Its high iodine content absorbs X-rays more effectively than surrounding tissues, allowing for clearer imaging of blood vessels, organs, and other structures.
The effects of Amidol Injection 300 mg/ml are immediate upon administration. It enhances imaging contrast within seconds to minutes, depending on the procedure and the area being imaged. The duration of the contrast effect generally lasts for the duration of the imaging study.
Amidol Injection 300 mg/ml is administered directly into the body via injection or infusion, so systemic absorption is not a primary consideration. The contrast medium stays within the blood vessels or the area of interest during the imaging procedure.
Amidol Injection 300 mg/ml is primarily excreted through the kidneys. After imaging procedures, it is filtered from the blood and eliminated from the body in the urine. A small portion may be eliminated through the feces.
The dosage of Amidol Injection 300 mg/ml varies depending on the imaging procedure:
Amidol Injection 300 mg/ml is administered via intravenous injection or infusion, depending on the imaging procedure. For myelography, it is injected into the spinal canal. The administration is typically performed by a trained radiologist or healthcare professional.
Common side effects include:
Toxicity of Amidol Injection 300 mg/ml is generally low when used as directed. Overdose or extravasation (leakage outside the blood vessels) can lead to local tissue damage or systemic effects. Symptoms of toxicity may include severe allergic reactions, kidney dysfunction, or significant discomfort at the injection site. Immediate medical attention is required for severe adverse reactions.
Precautions include:
Amidol Injection 300 mg/ml may interact with:
Use with caution in patients with:
Drug interactions with Amidol Injection 300 mg/ml include:
There are no significant food interactions with Amidol Injection 300 mg/ml. However, maintaining adequate hydration before and after the imaging procedure is recommended.
Amidol Injection 300 mg/ml is classified as pregnancy category C. It should be used during pregnancy only if the potential benefits outweigh the risks. The effects of Amidol Injection 300 mg/ml on fetal development are not well-studied, so it should be administered with caution and only if absolutely necessary.
Amidol Injection 300 mg/ml is excreted in breast milk in small amounts. While it is generally considered safe for use during lactation, caution is advised. Monitor for any potential adverse effects in the nursing infant, and consult a healthcare provider if concerns arise.
In the event of an overdose or excessive exposure, symptoms may include severe allergic reactions, kidney dysfunction, or significant discomfort. Treatment involves discontinuing the contrast agent and providing supportive care. Hydration and monitoring of renal function are crucial.
Amidol Injection 300 mg/ml is contraindicated in patients with:
Use Amidol Injection 300 mg/ml as directed by a healthcare professional. Follow the instructions for administration and dosage based on the imaging procedure. Ensure pre-procedure assessment and hydration, and follow any post-procedure guidelines provided by the radiology team.
Store Amidol Injection 300 mg/ml at room temperature, between 15°C and 30°C (59°F and 86°F). Protect from light and avoid freezing. Keep the medication in its original container and out of reach of children.
The volume of distribution for Amidol Injection 300 mg/ml is relatively low because it remains primarily within the vascular compartment and does not extensively distribute into tissues.
The elimination half-life of Amidol Injection 300 mg/ml is approximately 2 to 3 hours. The contrast medium is rapidly cleared from the bloodstream and excreted through the kidneys.
Amidol Injection 300 mg/ml is primarily cleared by the kidneys. The renal clearance rate is approximately 100 to 150 mL/min, and this may vary based on individual renal function and hydration status.
See in details version Amidol Injection 300 mg/ml also Amidol Injection 300 mg/ml in bangla
Dr. Md. Nazibur Rahman Khokon
Rheumatology, Arthritis & Medicine Specialist
Rheumatology Doctor in Chittagong
Prof. Dr. Md. Enamul Karim
Medicine, Diabetes & Hormone Specialist
Medicine Specialist Doctor in Dhaka